RIPK1 and systemic inflammatory response syndrome: Together, our results suggested that ketamine improved the ubiquitination of RIP1 after TNF-α stimulation, and with further molecular understanding of the mechanisms, ketamine may be a promising candidate therapeutic strategy for SIRS-related organ dysregulation.